Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells

Hepatology

Volumn 40, Issue 3, 2004, Pages 609-617

  Yokoo, Hideki ^a,b   Kondo, Tadashi ^a   Fujii, Kazuyasu ^b   Yamada, Tesshi ^a   Todo, Satoru ^b   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; FLUORESCENT DYE; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CONTROLLED STUDY; CYTOSKELETON; FLUORESCENCE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL CARCINOMA; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEOMICS; RNA TRANSLATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; BIOSYNTHESIS; CHEMISTRY; LIVER TUMOR; TUMOR CELL LINE;

ALPHA-FETOPROTEINS; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; MASS SPECTROMETRY; NEOPLASM PROTEINS; PROTEOMICS;

EID: 4544278712     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20372     Document Type: Article

References (47)

1. Okuda K. Heparocellular carcinoma. J Hepatol 2000;32(Suppl 1):225-237.
2. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999;353:1253-1257.
3. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,207 men in Taiwan. Lancet 1981;2:1129-1133.
4. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T, et al. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes Cancer 1995;13:163-167.
5. Tsuda H, Zhang WD, Shimosato Y, Yokota J, Terada M, Sugimura T, et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990;87:6791-6794.
6. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis-a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. HEPATOLOGY 2000;32:970-979.
7. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long term results of treatment and prognostic factors. Ann Surg 1999;229:216-222.
8. Leung TW, Patt YZ, Lau WY, Ho SK, Yu SC, Chan AT, et al. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 1999;5:1676-1681.
9. Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K. Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 2002;62:57-63.
10. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, et al. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 2000;31:302-308.
11. Gillespie JR, Uversky VN. Structure and function of alpha-fetoprotein: a biophysical overview. Biochim Biophys Acta 2000;1480:41-56.
12. Semenkova LN, Dudich EI, Dudich IV, Shingarova LN, Korobko VG. Alpha-fetoprotein as a TNF-resistance factor for human hepatocarcinoma cell line HepG2. Tumor Biol 1997;18:30-40.
13. Soloff MS, Swartz SK, Pearlmutter AF, Kithier K. Binding of 17beta-estradiol by variants of alpha-fetoprotein in rat amniotic fluid. Biochim Biophys Acta 1976;427:644-651.
14. Parmelee DC, Evenson MA, Deutsch HF. The presence of fatty acids in human alpha-fetoprotein. J Biol Chem 1978;253:2114-2119.
15. Ruoslahti E, Estes T, Seppala M. Binding of bilirubin by bovine and human alpha-fetoprotein. Biochim Biophys Acta 1979;578:511-519.
16. Lu CY, Changelian PS, Unanue ER. Alpha-fetoprotein inhibits macrophage expression of Ia antigens. J Immunol 1984;132:1722-1727.
17. Mizejewski GJ. Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Exp Biol Med 2001;226:377-408.
18. Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, Mori N, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003;361:923-929.
19. Kawai HF, Kaneko S, Honda M, Shirota Y, Kobayashi K. Alpha-fetoprotein- producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. HEPATOLOGY 2001;33:676-691.
20. Lee JS, Thorgeirsson SS. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. HEPATOLOGY 2002;35:1134-1143.
21. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720-1730.
22. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18:533-537.
23. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L, et al. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 2002;1:323-333.
24. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002;1:304-313.
25. Genda T, Sakamoto M, Ichida T, Asakura H, Kojiro M, Narumiya S, et al. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. HEPATOLOGY 1999;30:1027-1036.
26. Noguchi M, Hirohashi S. Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient. In Vitro Cell Dev Biol Anim 1996;32:135-137.
27. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M, et al. Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone. J Gastoenterol Hepatol 2001;16:1290-1296.
28. Pepinsky RB, Sinclair LK. Epidermal growth factor-dependent phosphorylation of lipocortin. Nature 1986;321:81-84.
29. Khanna NC, Tokuda M, Chong SM, Waisman DM. Phosphorylation of p36 in vitro by protein kinase C. Biochem Biophys Res Commun 1986;137:397-403.
30. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-212.
31. Masaki T, Tokuda M, Ohnishi M, Watanabe S, Fujimura T, Miyamoto K, et al. Enhanced expression of the protein kinase substrate Annexin 1 in human hepatocellular carcinoma. HEPATOLOGY 1996;24:72-81.
32. Dudich E, Semenkova L, Dudich I, Gorbatova E, Tochtamisheva N, Tatulov E, et al. Alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases. Eur J Biochem 1999;266:750-761.
33. Yamamoto K, Takenaka K, Kajiyama K, Shimada M, Shirabe K, Taketomi A, et al. Cell proliferation and cell loss in nodule-in-nodule hepatocellular carcinoma. Hepatogastroenterology 1999;46:813-819.
34. Taketa K, Shimamura J, Ueda M, Shimada Y, Kosaka K. Profiles of carbohydrate-metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers. Cancer Res 1988;48:467-474.
35. Yanagawa Y, Chen JC, Hsu LC, Yoshida A. The transcriptional regulation of human aldehyde dehydrogenase I gene. The structural and functional analysis of the promoter. J Biol Chem 1995;270:17521-17527.
36. Seow TK, Ong SE, Liang RC, Ren EC, Chan L, Ou K, et al. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis 2000;21:1787-1813.
37. Fiermonte G, Dolce V, Arrigoni R, Runswick MJ, Walker JE, Palmieri F. Organization and sequence of the gene for the human mitochondrial dicarboxylate carrier: evolution of the carrier family. Biochem J 1999;344:953-960.
38. Poirier F, Bourin P, Bladier D, Joubert-Caron R, Caron M. Effect of 5-azacytidine and galectin 1 on growth and differentiation of the human B lymphoma cell line bl36. Cancer Cell Int 2001;1:1-12.
39. Chen GG, Lai PB, Chan PK, Chak EC, Yip JH, Ho RL, et al. Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein. Eur J Cancer 2001;37:1695-1702.
40. Ravi R, Bedi A. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Cancer Res 2002;62:4180-4185.
41. Huang CJ, Severin E, Blum M. Flow-cytometric determination of dehydrogenase activities in primary human gastrointestinal tumor cell lines. Anal Cell Pathol 1994;6:93-103.
42. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001;61:889-895.
43. Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 2003;94:851-857.
44. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996;11:758-764.
45. Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, et al. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 1999;59:4990-4996.
46. Barnard GF, Staniunas RJ, Mori M, Puder M, Jessup MJ, Steele GD Jr, et al. Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma. Cancer Res 1993;53:4048-4052.
47. Ben-Ze'ev A. The use of two-dimensional gel electrophoresis in studies on the role of cytoskeletal plaque proteins as tumor suppressors. Electrophoresis 1996;17:1752-1763.